| Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review LS Ter Maat, IAJ van Duin, SG Elias, PJ van Diest, JPW Pluim, ... European Journal of Cancer 175, 60-76, 2022 | 21 | 2022 |
| CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma LS Ter Maat, IAJ van Duin, SG Elias, T Leiner, JJC Verhoeff, ERAN Arntz, ... European Journal of Cancer 185, 167-177, 2023 | 5 | 2023 |
| Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma IAJ van Duin, M Schuiveling, LS Ter Maat, WAC van Amsterdam, ... European Journal of Cancer 208, 114190, 2024 | 3 | 2024 |
| Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study LS ter Maat, IAJ Van Duin, RJ Verheijden, P Moeskops, JJC Verhoeff, ... medRxiv, 2024.03. 01.24303607, 2024 | | 2024 |
| Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma LS ter Maat, RAJ De Mooij, IAJ Van Duin, JJC Verhoeff, SG Elias, T Leiner, ... medRxiv, 2023.07. 25.23293133, 2023 | | 2023 |
| CT radiomics to predict checkpoint inhibitors treatment outcomes in patients with advanced cutaneous melanoma LS ter Maat, IAJ van Duin, SG Elias, T Leiner, JJC Verhoeff, E Arntz, ... medRxiv, 2022.12. 19.22283574, 2022 | | 2022 |
